Literature DB >> 2616255

Half-life of maternal labetalol in a premature infant.

A Haraldsson1, W Geven.   

Abstract

Intra-uterine heart arrhythmia, postpartal respiratory insufficiency, bradycardia and hypoglycaemia were observed in a premature infant (37 weeks gestational age) delivered by a caesarian section. The mother had been treated with adequate doses of labetalol because of pregnancy-induced hypertension and her plasma concentration was found to be 89 micrograms/l one day after delivery. The half-life of labetalol in the plasma of the infant was found to be approximately 24 h, i.e. substantially longer than in normal adults. The half-life of labetalol in newborn premature infants may be prolonged as compared to normal adults. More studies are required regarding the pharmacokinetics of this agent in premature infants and newborn babies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2616255     DOI: 10.1007/bf01959416

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  17 in total

1.  Propranolol administration during pregnancy: effects on the fetus.

Authors:  G R Gladstone; A Hordof; W M Gersony
Journal:  J Pediatr       Date:  1975-06       Impact factor: 4.406

2.  Effects on the neonate of propranolol administered during pregnancy.

Authors:  A Habib; J S McCarthy
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

3.  Severe adverse effects of maternal labetalol in a premature infant.

Authors:  A Haraldsson; W Geven
Journal:  Acta Paediatr Scand       Date:  1989-11

Review 4.  Current concepts: beta-blockers in pregnancy.

Authors:  P C Rubin
Journal:  N Engl J Med       Date:  1981-11-26       Impact factor: 91.245

5.  Side effects of labetalol in newborn infants.

Authors:  D L Woods; A F Malan
Journal:  Br J Obstet Gynaecol       Date:  1983-09

6.  Neonatal effects of maternal administration of acebutolol.

Authors:  Y Dumez; C Tchobroutsky; H Hornych; C Amiel-Tison
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-24

7.  Atenolol: side effects in a newborn infant.

Authors:  D L Woods; D F Morrell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11

8.  Decreased first-pass metabolism of labetalol in chronic liver disease.

Authors:  M Homeida; L Jackson; C J Roberts
Journal:  Br Med J       Date:  1978-10-14

9.  Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol.

Authors:  H Lardoux; J Gerard; G Blazquez; F Chouty; B Flouvat
Journal:  Eur Heart J       Date:  1983-11       Impact factor: 29.983

10.  Metabolism of labetalol by animals and man.

Authors:  L E Martin; R Hopkins; R Bland
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

View more
  3 in total

1.  Adverse neonatal effects of maternal labetalol treatment.

Authors:  B N Crooks; S A Deshpande; C Hall; M P Platt; D W Milligan
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

Review 2.  Clinical pharmacokinetics of vasodilators. Part II.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

Review 3.  The Risk for Neonatal Hypoglycemia and Bradycardia after Beta-Blocker Use during Pregnancy or Lactation: A Systematic Review and Meta-Analysis.

Authors:  Rosalie de Bruin; Sarah L van Dalen; Shamaya J Franx; Viraraghavan V Ramaswamy; Sinno H P Simons; Robert B Flint; Gerbrich E van den Bosch
Journal:  Int J Environ Res Public Health       Date:  2022-08-04       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.